Op/ed: Philanthropy is caught in a game of politics
In spite of the importance of addressing long-term fiscal imbalances, fooling with the philanthropic engine strikes me as short-sighted.
Editorial: Domestic violence is a business issue, too
We’ve been reminded recently of the tremendous toll that domestic violence takes on our region’s families and our economy and of the need for businesses to participate in dealing with this issue.
Amgen is Big Pharma’s newest player
Nov. 7, 2011 should be remembered as the date when Amgen resigned its charter membership in the biotech growth club and joined Big Pharma.
Editorial: Haas drives high-tech manufacturing training
The Oxnard businessman is providing an additional $150,000 in funding to the Society of Manufacturing Engineers Foundation to create a series of Gene Haas Scholarships.
Post-Madoff era still rife with schemes
Ponzi schemes, insider trading and mortgage fraud have sunk white collar crimes into their lowest nadir since the junk bond era.
